ROCHE FDA Approval NDA 012715

NDA 012715

ROCHE

FDA Drug Application

Application #012715

Application Sponsors

NDA 012715ROCHE

Marketing Status

Discontinued002
Discontinued003

Application Products

002TABLET;ORAL500MG0GANTANOLSULFAMETHOXAZOLE
003TABLET;ORAL1GM0GANTANOL-DSSULFAMETHOXAZOLE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1965-08-25STANDARD
LABELING; LabelingSUPPL19AP1977-05-04
LABELING; LabelingSUPPL20AP1978-01-05
LABELING; LabelingSUPPL24AP1978-05-04
LABELING; LabelingSUPPL25AP2001-09-17
LABELING; LabelingSUPPL27AP2001-09-17
LABELING; LabelingSUPPL29AP2001-09-17

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 12715
            [companyName] => ROCHE
            [docInserts] => ["",""]
            [products] => [{"drugName":"GANTANOL","activeIngredients":"SULFAMETHOXAZOLE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"GANTANOL-DS","activeIngredients":"SULFAMETHOXAZOLE","strength":"1GM","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"GANTANOL","submission":"SULFAMETHOXAZOLE","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"GANTANOL-DS","submission":"SULFAMETHOXAZOLE","actionType":"1GM","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.